Incannex Healthcare (IXHL) Competitors $0.84 +0.35 (+70.13%) Closing price 04/8/2025 04:00 PM EasternExtended Trading$0.70 -0.14 (-16.82%) As of 09:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock IXHL vs. BDRX, ONCY, BLUE, AADI, IMMX, PEPG, NBRV, PDSB, STTK, and MDCXShould you be buying Incannex Healthcare stock or one of its competitors? The main competitors of Incannex Healthcare include Biodexa Pharmaceuticals (BDRX), Oncolytics Biotech (ONCY), bluebird bio (BLUE), Aadi Bioscience (AADI), Immix Biopharma (IMMX), PepGen (PEPG), Nabriva Therapeutics (NBRV), PDS Biotechnology (PDSB), Shattuck Labs (STTK), and Medicus Pharma (MDCX). These companies are all part of the "pharmaceutical products" industry. Incannex Healthcare vs. Biodexa Pharmaceuticals Oncolytics Biotech bluebird bio Aadi Bioscience Immix Biopharma PepGen Nabriva Therapeutics PDS Biotechnology Shattuck Labs Medicus Pharma Biodexa Pharmaceuticals (NASDAQ:BDRX) and Incannex Healthcare (NASDAQ:IXHL) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, valuation, media sentiment, dividends, analyst recommendations, community ranking, institutional ownership and profitability. Which has stronger earnings and valuation, BDRX or IXHL? Biodexa Pharmaceuticals has higher earnings, but lower revenue than Incannex Healthcare. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBiodexa Pharmaceuticals$83K620.81-$7.66MN/AN/AIncannex Healthcare$98K152.92-$18.46M-$1.39-0.60 Does the MarketBeat Community favor BDRX or IXHL? Biodexa Pharmaceuticals received 1 more outperform votes than Incannex Healthcare when rated by MarketBeat users. CompanyUnderperformOutperformBiodexa PharmaceuticalsOutperform Votes1100.00% Underperform VotesNo VotesIncannex HealthcareN/AN/A Which has more risk and volatility, BDRX or IXHL? Biodexa Pharmaceuticals has a beta of 1.7, indicating that its stock price is 70% more volatile than the S&P 500. Comparatively, Incannex Healthcare has a beta of 7.54, indicating that its stock price is 654% more volatile than the S&P 500. Is BDRX or IXHL more profitable? Biodexa Pharmaceuticals' return on equity of 0.00% beat Incannex Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets Biodexa PharmaceuticalsN/A N/A N/A Incannex Healthcare N/A -289.30%-154.96% Does the media prefer BDRX or IXHL? In the previous week, Incannex Healthcare had 6 more articles in the media than Biodexa Pharmaceuticals. MarketBeat recorded 6 mentions for Incannex Healthcare and 0 mentions for Biodexa Pharmaceuticals. Biodexa Pharmaceuticals' average media sentiment score of 0.00 equaled Incannex Healthcare'saverage media sentiment score. Company Overall Sentiment Biodexa Pharmaceuticals Neutral Incannex Healthcare Neutral Do insiders and institutionals believe in BDRX or IXHL? 17.5% of Biodexa Pharmaceuticals shares are owned by institutional investors. Comparatively, 0.4% of Incannex Healthcare shares are owned by institutional investors. 0.3% of Biodexa Pharmaceuticals shares are owned by company insiders. Comparatively, 26.5% of Incannex Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. SummaryBiodexa Pharmaceuticals beats Incannex Healthcare on 6 of the 10 factors compared between the two stocks. Remove Ads Get Incannex Healthcare News Delivered to You Automatically Sign up to receive the latest news and ratings for IXHL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IXHL vs. The Competition Export to ExcelMetricIncannex HealthcarePharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$14.99M$6.10B$5.08B$6.91BDividend YieldN/A2.93%5.34%4.25%P/E Ratio-0.606.5321.1917.05Price / Sales152.92185.84339.0785.99Price / CashN/A65.6738.1534.64Price / Book16.785.356.013.66Net Income-$18.46M$141.19M$3.19B$247.27M7 Day Performance30.50%-12.28%-8.98%-9.80%1 Month Performance-3.56%-20.11%-6.92%-12.84%1 Year Performance-72.49%-22.71%0.40%-10.68% Incannex Healthcare Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IXHLIncannex Healthcare0.3576 of 5 stars$0.84+70.1%N/A-73.1%$14.99M$98,000.00-0.603High Trading VolumeBDRXBiodexa Pharmaceuticals0.1488 of 5 stars$1.32+7.3%N/AN/A$48.24M$83,000.000.0020Gap DownONCYOncolytics Biotech1.1798 of 5 stars$0.55-8.3%$4.00+627.3%-57.8%$47.53MN/A-2.0430BLUEbluebird bio2.6511 of 5 stars$4.88+19.6%$44.60+813.9%-79.2%$47.44M$53.12M-0.13520Gap UpHigh Trading VolumeAADIAadi Bioscience0.9121 of 5 stars$1.91+0.5%$1.67-12.7%-23.3%$47.17M$25.07M-0.8440Positive NewsIMMXImmix Biopharma1.8177 of 5 stars$1.68-1.2%$7.00+316.7%-52.4%$46.57MN/A-1.989Positive NewsPEPGPepGen1.923 of 5 stars$1.41-5.1%$10.33+635.5%-91.9%$45.93MN/A-0.4730Gap UpNBRVNabriva TherapeuticsN/AN/AN/AN/A$45.46M$35.59M0.0070PDSBPDS Biotechnology1.41 of 5 stars$1.19-5.6%$9.00+656.3%-71.7%$45.45MN/A-1.0320Gap UpSTTKShattuck Labs1.9964 of 5 stars$0.95-9.9%$7.50+689.4%-89.6%$45.36M$5.72M-0.62100Gap DownMDCXMedicus PharmaN/A$3.72+18.8%$10.00+168.8%N/A$44.35MN/A0.00N/APositive NewsGap Up Remove Ads Related Companies and Tools Related Companies Biodexa Pharmaceuticals Alternatives Oncolytics Biotech Alternatives bluebird bio Alternatives Aadi Bioscience Alternatives Immix Biopharma Alternatives PepGen Alternatives Nabriva Therapeutics Alternatives PDS Biotechnology Alternatives Shattuck Labs Alternatives Medicus Pharma Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IXHL) was last updated on 4/9/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Incannex Healthcare Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Incannex Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IXHL Stock Free IXHL Stock Alerts